The global hemostats market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing number of surgeries and rising incidence of cardiovascular diseases. The global hemostats market is segmented on the basis of type, application, and region. On the basis of type, it is segmented into thrombi-based hemostats, oxidized regenerated cellulose based hemostats, combination hemostats, gelatine based hemostats and collagen based hemostats. On the basis of application it is segmented into prehospital treatment and hospital treatment. Geographically it has been classified into North America (US & Canada), Latin America (Mexico & Brazil), Europe (UK & Germany), Asia Pacific (China & Japan) and Middle East & Africa (Saudi Arabia).
Some Of The Growth Factors Of This Market:
- Increasing awareness about the benefits of hemostats over conventional methods such as sutures and stitches is also expected to fuel growth in this market during the forecast period.
- The rising geriatric population base across developed economies is also anticipated to boost demand for hemostats in the near future due to their ease-of-use and safety features when compared with conventional methods like sutures and stitches that require more skill on part of medical practitioners for successful application.
Industry Growth Insights published a new data on “Hemostats Market”. The research report is titled “Hemostats Market research by Types (Thrombin-Based Hemostats, Oxidized Regenerated Cellulose Based Hemostats, Combination Hemostats, Gelatin Based Hemostats, Collagen Based Hemostats), By Applications (Prehospital Treatment, Hospital Treatment), By Players/Companies Ethicon, Pfizer, Baxter International Inc., C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences Corporation, B Braun Melsungen AG, Gelita Medical GmbH, Equimedical, Vascular Solutions, Marine Polymer Technologies, Z-Medica, LLC, CryoLife, BioCer Entwicklungs-GmbH., Biom'Up SAS”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Hemostats Market Research Report
By Type
Thrombin-Based Hemostats, Oxidized Regenerated Cellulose Based Hemostats, Combination Hemostats, Gelatin Based Hemostats, Collagen Based Hemostats
By Application
Prehospital Treatment, Hospital Treatment
By Companies
Ethicon, Pfizer, Baxter International Inc., C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences Corporation, B Braun Melsungen AG, Gelita Medical GmbH, Equimedical, Vascular Solutions, Marine Polymer Technologies, Z-Medica, LLC, CryoLife, BioCer Entwicklungs-GmbH., Biom'Up SAS
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Hemostats Market Report Segments:
The global Hemostats market is segmented on the basis of:
Types
Thrombin-Based Hemostats, Oxidized Regenerated Cellulose Based Hemostats, Combination Hemostats, Gelatin Based Hemostats, Collagen Based Hemostats
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Prehospital Treatment, Hospital Treatment
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ethicon
- Pfizer
- Baxter International Inc.
- C. R. Bard
- The Medicines Company
- Anika Therapeutics
- Advanced Medical Solutions
- Integra LifeSciences Corporation
- B Braun Melsungen AG
- Gelita Medical GmbH
- Equimedical
- Vascular Solutions
- Marine Polymer Technologies
- Z-Medica, LLC
- CryoLife
- BioCer Entwicklungs-GmbH.
- Biom'Up SAS
Highlights of The Hemostats Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Thrombin-Based Hemostats
- Oxidized Regenerated Cellulose Based Hemostats
- Combination Hemostats
- Gelatin Based Hemostats
- Collagen Based Hemostats
- By Application:
- Prehospital Treatment
- Hospital Treatment
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hemostats Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hemostats are a type of medical device used to temporarily stop bleeding. They come in various shapes and sizes, including clamps, bandages, and tourniquets.
Some of the major players in the hemostats market are Ethicon, Pfizer, Baxter International Inc., C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences Corporation, B Braun Melsungen AG, Gelita Medical GmbH, Equimedical, Vascular Solutions, Marine Polymer Technologies, Z-Medica, LLC, CryoLife, BioCer Entwicklungs-GmbH., Biom'Up SAS.
The hemostats market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hemostats Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Hemostats Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Hemostats Market - Supply Chain
4.5. Global Hemostats Market Forecast
4.5.1. Hemostats Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Hemostats Market Size (000 Units) and Y-o-Y Growth
4.5.3. Hemostats Market Absolute $ Opportunity
5. Global Hemostats Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Hemostats Market Size and Volume Forecast by Type
5.3.1. Thrombin-Based Hemostats
5.3.2. Oxidized Regenerated Cellulose Based Hemostats
5.3.3. Combination Hemostats
5.3.4. Gelatin Based Hemostats
5.3.5. Collagen Based Hemostats
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Hemostats Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Hemostats Market Size and Volume Forecast by Application
6.3.1. Prehospital Treatment
6.3.2. Hospital Treatment
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Hemostats Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Hemostats Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Hemostats Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Hemostats Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Hemostats Demand Share Forecast, 2019-2026
9. North America Hemostats Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Hemostats Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Hemostats Market Size and Volume Forecast by Application
9.4.1. Prehospital Treatment
9.4.2. Hospital Treatment
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Hemostats Market Size and Volume Forecast by Type
9.7.1. Thrombin-Based Hemostats
9.7.2. Oxidized Regenerated Cellulose Based Hemostats
9.7.3. Combination Hemostats
9.7.4. Gelatin Based Hemostats
9.7.5. Collagen Based Hemostats
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Hemostats Demand Share Forecast, 2019-2026
10. Latin America Hemostats Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Hemostats Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Hemostats Market Size and Volume Forecast by Application
10.4.1. Prehospital Treatment
10.4.2. Hospital Treatment
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Hemostats Market Size and Volume Forecast by Type
10.7.1. Thrombin-Based Hemostats
10.7.2. Oxidized Regenerated Cellulose Based Hemostats
10.7.3. Combination Hemostats
10.7.4. Gelatin Based Hemostats
10.7.5. Collagen Based Hemostats
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Hemostats Demand Share Forecast, 2019-2026
11. Europe Hemostats Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Hemostats Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Hemostats Market Size and Volume Forecast by Application
11.4.1. Prehospital Treatment
11.4.2. Hospital Treatment
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Hemostats Market Size and Volume Forecast by Type
11.7.1. Thrombin-Based Hemostats
11.7.2. Oxidized Regenerated Cellulose Based Hemostats
11.7.3. Combination Hemostats
11.7.4. Gelatin Based Hemostats
11.7.5. Collagen Based Hemostats
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. arket Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Hemostats Demand Share, 2019-2026
12. Asia Pacific Hemostats Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Hemostats Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Hemostats Market Size and Volume Forecast by Application
12.4.1. Prehospital Treatment
12.4.2. Hospital Treatment
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Hemostats Market Size and Volume Forecast by Type
12.7.1. Thrombin-Based Hemostats
12.7.2. Oxidized Regenerated Cellulose Based Hemostats
12.7.3. Combination Hemostats
12.7.4. Gelatin Based Hemostats
12.7.5. Collagen Based Hemostats
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Hemostats Demand Share, 2019-2026
13. Middle East & Africa Hemostats Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Hemostats Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Hemostats Market Size and Volume Forecast by Application
13.4.1. Prehospital Treatment
13.4.2. Hospital Treatment
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Hemostats Market Size and Volume Forecast by Type
13.7.1. Thrombin-Based Hemostats
13.7.2. Oxidized Regenerated Cellulose Based Hemostats
13.7.3. Combination Hemostats
13.7.4. Gelatin Based Hemostats
13.7.5. Collagen Based Hemostats
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Hemostats Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Hemostats Market: Market Share Analysis
14.2. Hemostats Distributors and Customers
14.3. Hemostats Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Ethicon
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Pfizer
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Baxter International Inc.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. C. R. Bard
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. The Medicines Company
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Anika Therapeutics
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Advanced Medical Solutions
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Integra LifeSciences Corporation
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. B Braun Melsungen AG
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Gelita Medical GmbH
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Equimedical
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Vascular Solutions
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Marine Polymer Technologies
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Z-Medica, LLC
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. CryoLife
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. BioCer Entwicklungs-GmbH.
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Biom'Up SAS
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook